NRIX - Nurix Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NRIX is currently covered by 12 analysts with an average price target of $31.57. This is a potential upside of $12.31 (23.66%) from yesterday's end of day stock price of $25.53.

Nurix Therapeutics 's activity chart (see below) currently has 180 price targets and 178 ratings on display. The stock rating distribution of NRIX is 94.34% BUY and 5.66% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.45% with an average time for these price targets to be met of 142.67 days.

Highest price target for NRIX is $40, Lowest price target is $23, average price target is $31.57.

Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 28-Jul-2026. First documented stock forecast 18-Aug-2020.

Best performing analysts who are covering NRIX - Nurix Therapeutics :

Mark Breidenbach Joel Beatty Derek Archila Stephen Willey Eric Joseph Gregory Renza

Currently out of the existing stock ratings of NRIX, 50 are a BUY (94.34%), 3 are a HOLD (5.66%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Jul-2026

$38

$14.79 (63.72%)

$36

Buy Since 10-Apr-2025

$31

$7.79 (33.56%)

$30

Buy Since 27-Oct-2021

$34

$10.79 (46.49%)

$35

Buy Since 18-Aug-2020

$40

$16.79 (72.34%)

$35

Buy Since 13-Jun-2025

$33

$9.79 (42.18%)

$30

Show more analysts

Please expand the browser size to see the chart

What is NRIX (Nurix Therapeutics ) average time for price targets to be met?

On average it took 142.67 days on average for the stock forecasts to be realized with a an average price target met ratio 33.45

Which analyst has the current highest performing score on NRIX (Nurix Therapeutics ) with a proven track record?

MARK BREIDENBACH

Which analyst has the most public recommendations on NRIX (Nurix Therapeutics )?

Mark Breidenbach has 5 price targets and 7 ratings on NRIX

Which analyst is the currently most bullish on NRIX (Nurix Therapeutics )?

Chad Messer with highest potential upside - $31.97

Which analyst is the currently most reserved on NRIX (Nurix Therapeutics )?

Faisal Khurshid with lowest potential downside - -$7.21

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?